Suchergebnisse - "Wegmann, Frank"

PubPharm (93)

1

Immunogenicity and protective efficacy of one- and two-dose regimens of the Ad26.COV2.S COVID-19 vaccine candidate in adult and aged rhesus macaques

enthalten in: bioRxiv.org | 2024

von Solforosi, L. | Kuipers, H. | Huber, S. | +34

2

CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbits

enthalten in: Nature communications | 2024

von Koornneef, A. | Vanshylla, K. | Hardenberg, G. | +16

3

POXVIRUS VECTORS ENCODING HIV ANTIGENS, AND METHODS OF USE THEREOF

enthalten in: Europäisches Patentamt | 2024

von WEGMANN FRANK | LANGEDIJK JOHANNES PETRUS MARIA | CUSTERS JEROME HUBERTINA HENRICUS VICTOR | +2

4

Immunodeficiency virus type 1 (HIV-1) mutant envelope proteins

enthalten in: Europäisches Patentamt | 2024

von LANGEDIJK JOHANNES PETRUS MARIA | VAN MANEN DANIELLE | VELLINGA JORT | +4

5

Immunodeficiency virus type 1 (HIV-1) mutant envelope proteins

enthalten in: Europäisches Patentamt | 2024

von LANGEDIJK JOHANNES PETRUS MARIA | VAN MANEN DANIELLE | VELLINGA JORT | +4

6

Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques

enthalten in: Nature | 2024

von McMahan, K. | Wegmann, F. | Aid, M. | +27

7

Intravenous Administration of Ad26.COV2.S Does Not Induce Thrombocytopenia or Thrombotic Events or Affect SARS-CoV-2 Spike Protein Bioavailability in Blood Compared with Intramuscular Vaccination in Rabbits

enthalten in: Vaccines | 2023

von Khan, S. | Marquez-Martinez, S. | Erkens, T. | +11

8

Poxvirus vectors encoding HIV antigens, and methods of use thereof

enthalten in: Europäisches Patentamt | 2023

von WEGMANN FRANK | LANGEDIJK JOHANNES PETRUS MARIA | CUSTERS JERÔME HUBERTINA HENRICUS VICTOR | +2

9

Poxvirus vectors encoding HIV antigens, and methods of use thereof

enthalten in: Europäisches Patentamt | 2023

von WEGMANN FRANK | LANGEDIJK JOHANNES PETRUS MARIA | CUSTERS JERÔME HUBERTINA HENRICUS VICTOR | +2

10

Booster immunization with Ad26.COV2.S or Omicron adapted vaccine enhanced immune responses and efficacy against SARS-CoV-2 Omicron in non-human primates

enthalten in: ResearchSquare.com | 2023

von Solforosi, L. | Costes, L. | Tolboom, J. | +22

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]